Role for Linezolid in drug sensitive tuberculosis
Tuberculosis (TB) continues to be a global challenge. Reducing the duration of TB treatment for drug-sensitive TB (DSTB) has direct and distinct advantages. We ventured into the aspect of utilizing linezolid as a pivotal drug in shortening therapy in DSTB. Linezolid has gained prominence as it is fa...
Saved in:
Main Authors: | S. Ramesh Kumar (Author), G. Narendran (Author), C. Padmapriyadarsini (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Linezolid Pharmacokinetics and Its Association with Adverse Drug Reactions in Patients with Drug-Resistant Pulmonary Tuberculosis
by: Chandrasekaran Padmapriyadarsini, et al.
Published: (2023) -
Model-Informed Precision Dosing of Linezolid in Patients with Drug-Resistant Tuberculosis
by: Laurynas Mockeliunas, et al.
Published: (2022) -
Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment
by: Lina Keutzer, et al.
Published: (2023) -
A Transcriptomic Biomarker Predicting Linezolid-Associated Neuropathy During Treatment of Drug-Resistant Tuberculosis
by: Nika Zielinski, et al.
Published: (2024) -
Linezolid-induced ringed sideroblastic anemia and thrombocytopenia in a child with extensively drug-resistant tuberculosis
by: Snigdha Sippy, et al.
Published: (2021)